Overview of radiation oncology in the Czech Republic  by PETERA, Jiri et al.
268 REP PRACT ONCOL RADIOTHER • 2008 • 13/6/: 268–274
INVITED PAPER
Overview of radiation oncology in the Czech 
Republic 
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SUMMARY
BACKGROUND: Modern radiotherapy (RT) plays a very important role in both curative and palliative 
treatment of tumours. There are large variations among the EU countries and even regional variations 
within countries in the provision of RT.  
AIM: In this report we present an overview of the current infrastructure, organisation, education and 
quality programme of radiotherapy in the Czech Republic. 
MATERIAL AND METHODS: Data from the National Cancer Registry, Institute of Health Information 
and Statistics of the Czech Republic and from questionnaires and clinical audits of radiotherapy de-
partments were used for evaluation of radiotherapy equipment, numbers of patients treated by radio-
therapy and workload of radiotherapy facilities. 
RESULTS: Radiotherapy of malignant diseases is provided in 28 facilities in the Czech Republic. There 
are 35 linear accelerators and 16 cobalt units for the population of 10.3 million inhabitants, which 
represents one megavoltage unit for 200 000 inhabitants. Fourteen departments are equipped for 
brachytherapy with high dose rate afterloading machines. Forty-three percent of newly reported can-
cer patients undergo radiotherapy as part of oncological treatment.
CONCLUSION: The main problem of radiation oncology in the Czech Republic is insuffi cient centralisa-
tion and the persistence of small, under-equipped departments. 
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The Czech Republic has a population of 10.4 
million inhabitants. The cancer incidence is 
very high. In 2005 the total number of cases 
of malignant neoplasms and carcinoma in situ 
(ICD-10 codes C00–C97 and D00–D09) newly 
reported to the National Cancer Registry was 
71 449. The mortality was 28 033 cases. While 
the level of incidence of malignant neoplasms 
in the Czech Republic increases, mortality 
has exhibited an opposite trend since the sec-
ond half of the 1990s (1).
The history of radiotherapy in Bohemia 
starts in the year of 1906 when the fi rst ra-
don spa in the world was founded in Jachymov 
(Joachimsthal). The uranium mines in Jachy-
mov were a source of 226Ra for brachytherapy 
until the nineteen sixties. The former Czecho-
slovakia in the second half of the 20th century 
was also a producer of cobalt and caesium 
units and betatrons, which helped to establish 
a national network of radiotherapy depart-
ments. In the 1990s it became evident that 
this network was too dense and it was diffi cult 
to equip all radiotherapy facilities with mod-
ern technology. The Czech Society for Radia-
tion Oncology, Biology and Physics (SROBF) 
prepared in the year 1995 technical and staff 
requirements and a quality assurance/control 
programme for radiotherapy departments and 
started to support centralization of curative 
radiotherapy to well equipped centres. This 
process is very slow, because until recently 
there was insuffi cient support from the Minis-
try of Health and of health insurance compa-
nies. The large state and university hospitals 
had only a limited budget for development of 
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radiotherapy, while small hospitals were very 
interested to keep radiotherapy departments 
and not to be forced to send their patients 
away. In the years 2004–2006 the SROBF pre-
pared national standards of radiation oncology 
and proposal of clinical audit of radiotherapy 
departments. This project was supported by 
the Ministry of Health. The standards de-
fi ne minimal infrastructure of radiotherapy 
departments and requirements for the qual-
ity of the process of radiotherapy. The stan-
dards are published on the website of the 
SROBF (www.srobf.cz) and were accepted by 
the Ministry of Health and health insurance 
companies; they are very helpful in negotia-
tions about reimbursement and the future of 
radiation oncology in the Czech Republic. The 
National Cancer Register has collected data 
about incidence and mortality of cancer in 
the Czech Republic since the 1950s and is a 
useful source of information about numbers 
of patients treated by radiotherapy and about 
the required capacity of radiotherapy. 
At present, radiotherapy of malignant dis-
eases is provided in 28 facilities (Fig. 1), but 
only half of them have at least two linear ac-
celerators. Both external beam radiotherapy 
Parameter1 European average 2003(2) Czech Republic2003 Czech Republic 2008
Number of MV per 106 of inhabitants 5.9 4.8 5
1MV/n 170 000 208 000 202 000 
LA/Co 3.26 0.96 2.2
1LA/n 222 222 416 000 294 000
1 MV = megavoltage unit; n = number of inhabitants; LU = linear accelerator; Co = cobalt unit
2 Source: Bentzen, Radiotherapy and Oncology, 75(2005), 355 – 365
Table 2. Radiotherapy equipment in the Czech Republic compared to the European data
RT machine 1999 2001 2003 2004 2008
Linear accelerator 17 18 24 28 35
60Co unit 30 28 25 21 16
Betatron  3  2  0         0   0
X-ray therapy 34 28 24 24 25
Afterloading brachytherapy 15 16 18 21 17
Simulator 17 18 19 22 28
Treatment planning system (TPS) 36 37 50 55
Table 1. Numbers of RT machines in the Czech Republic over the period 1999–2008
Fig. 1. Network of Czech radiotherapy facilities in 2007/2008
(A) UH Kralovske Vinohrady /Prague/, (B) General UH /Prague/, 
(C) Thomayer UH /Prague/, (D) UH in Motol /Prague/, (E) UH na Bu-
loyce /Prague/, (F) Kladno, (Ci) lnstitute of Oncology and Rehabili-
tation Ples, (H) Ceske Budejovice, (1) UH Pilsen, (K) Cheb, (L) Usti 
nad Labem, (M) Chomutov, (N) Liberec, (0) UH Hradec Kralove, 
(P) Pardubice, (Q) Trutnov; (R) Jicin, (S) Havlickuv Brod, 
(T) Masaryk memorial Cancer Institute /Brno/, (U) UH Brno, 
(V) St. Anne’s UH Brno, (W) Jihlava, (X) Znojmo, (Y) Prostejov, 
(Z) Holesov (AA) UH Ostrava, (AB) Uf I Olomouc, (AC) Novy Jicin. 
(Noto: UH = University Hospital)
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and brachytherapy are performed in 16 de-
partments. Twelve departments are at uni-
versity hospitals, 4 in regional hospitals, 3 are 
private and 9 are in local hospitals. An addi-
tional 10 facilities are equipped with ortho-
voltage X-ray units and serve for radiotherapy 
of non-malignant diseases, mostly painful de-
generative disorders. 
The equipment with modern technique is 
not satisfactory but is relatively fast improv-
ing (Table 1). At present, there is one linear 
accelerator per approximately 300 000 inhab-
itants and one megavoltage unit (linear ac-
celerators + cobalts) per 200 000 inhabitants. 
Table 2 provides a comparison with the Euro-
pean data. Twelve centres are able to perform 
intensity-modulated radiotherapy and 10 cen-
tres use image-guided radiotherapy. Stereot-
actic radiotherapy is provided by 2 university 
hospitals (University Hospital Motol, Prague 
and Masaryk Memorial Cancer Centre, Brno). 
The radiosurgery department of the Hospi-
tal Na Homolce, Prague, is equipped with a 
gamma knife. 
All 16 radiotherapy departments that pro-
vide brachytherapy are equipped with auto-
matic afterloading devices; from 18 afterload-
ers 14 are high dose rate and 4 low dose rate 
(Fig. 2).
The number of patients treated by radio-
therapy is monitored by the Institute of Health 
Information and Statistics of the Czech Repub-
lic. On average 43% of newly reported cancer 
patients undergo radiotherapy as part of onco-
logical treatment (Table 3). Numbers of new 
patients treated by radiotherapy and numbers 
of radiation oncologists in 28 radiation oncol-
ogy facilities across the Czech Republic are 
presented in Figure 3.   
In 2005 the SROBF with the support of the 
Ministry of Health carried out a survey fo-
cused on the structure, equipment, staff, treat-
ment quality and workload of radiotherapy fa-
cilities in the Czech Republic. This survey was 
part of preparation of on-site clinical audits. A 
questionnaire was sent to all 28 radiotherapy 
facilities. Selected data are presented in Table 
4 and Figures 4, 5.
Between 2004 and 2006 the SROBF per-
formed clinical audits at radiotherapy depart-
ments of 8 university hospitals. The project 
was supported by the Ministry of Health (in 
agreement with EC Directive 97/43). The aim 
Fig. 2. Growing accessibility of HDR afterloading devices in the 
Czech Republic (years 2002 and 2007)
Main cancer diagnoses No. of newly reported 
cancer patients1
No. of patientstreated 
with RT2
RT-treated patients 
(% of all reported cases)
Lung 6 242 2 389 38.3 %
Breast (females) 5 628 4 600 82.0 %
Prostate 4 289 1 674 39.0 %
Rectum 2 211 1 831 82.8 %
Corpus uteri 1 734 1 016 58.6 %
Cervix uteri 1 033 813 78.7 %
All cancer locations without skin cancer 53 522 23 079 43.0 %
1 Czech National Cancer Registry
2 Survey performed by the Czech Society for Radiation Oncology, Biology and Physics (SROBF).
Table 3. Newly reported cancer patients and the number of patients treated with radiotherapy in 2004
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Fig. 3. Number of newly diagnosed patients treated with RT and the number of radiation oncologists in 28 Czech radiation 
oncology facilities (2007)
of the audits was to evaluate whether the tech-
nical equipment, staff, numbers of patients, 
quality of oncological care and radiotherapy 
procedures, local treatment protocols and 
physical aspects of radiotherapy are in accor-
dance with national standards of radiation on-
cology. In most centres the audits helped the 
heads of radiotherapy departments in their 
negotiations with hospital management and 
their effort to improve the quality of radiation 
oncology. Unfortunately, the project of clini-
cal audits was discontinued by the Ministry of 
Health in 2007.
A more recent overview of radiotherapy in 
the Czech Republic was obtained in 2007 when 
the European Society for Therapeutic Radiol-
ogy and Oncology (ESTRO) organized a sur-
vey called Patterns of Care of Brachytherapy. 
The results are summarized in Tables 5 and 6. 
The State Offi ce for Nuclear Safety (SUJB) 
publishes quality assurance recommendations 
for radiation oncology and performs regular 
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Facility 
No.
All 
patients 
treated 
with RT
New 
patients 
treated 
with RT
New 
patients- 
tele-
therapy
New 
patients 
– brachy-
therapy
No. 
of LA
No. of60
Co units
Fieldsper1 
LA
Fieldsper 
60Co 
unit
Waiting 
time 
for RT 
(days)
1 1820 1672 1653 181 2 0 40492 0 16
2 368 220 180 165 0 1 0 5909 3–7
3 2759 891 891 0 1 1 24208 19974 15
4 2123 878 870 115 2 0 45201 0 15
5 1508 1060 813 341 2 1 26459 8389 10
6 2897 1077 1021 88 1 1 47683 28794 2
7 1023 813 801 158 2 1 43050 15514 45
8 1456 1262 1210 174 3 0 29916 0 21
9 830 620 620 39 0 1 0 34482 7–10
10 1226 882 861 134 3 0 25393 0 5
11 254 200 200 0 0 1 0 NR 7
12 1106 936 906 126 1 1 86211 17119 26
13 2511 823 823 59 2 0 28587 0 10
14 465 437 437 0 1 1 30500 100 10
15 1659 728 554 174 2 1 45926 1734 21
16 211 190 190 0 0 1 0 18100 7-10
17 563 532 532 0 0 1 0 44503 4
18 279 249 249 0 0 1 0 24127 10
19 796 507 487 62 1 0 39567 1595 14
20 154 149 149 0 0 1 0 6609 1
21 1013 980 980 19 1 1 49730 17197 5–21
22 950 825 825 26 1 1 63900 368 7
23 524 420 420 0 0 1 0 11736 5
24 83 83 83 0 0 1 0 5139 4
25 404 362 321 0 0 1 0 20756 5
26 1118 509 484 33 1 1 32190 7210 14
27 389 348 321 0 0 1 0 12183 4
28 1215 1215 1215 97 2 0 52500 0 2-3
Total 29704 18868 18096 1991 28 21
LA = linear accelerator, RT = radiotherapy, NR = not reported
Table 4. The number of patients treated with radiotherapy and the number of irradiated fi elds (2004)
audits of radiotherapy departments. Audits 
have the following tasks:
– to perform an independent quality check of 
the radiotherapy equipment
– to unify the dose evaluation in all radiothera-
py departments in the Czech Republic
– to improve clinical practice and professional 
supervision.     
Both on-site audits (maximally 5-year peri-
od) and correspondence dosimetric audits are 
used. In addition some radiotherapy depart-
ments also participate in international audits 
organised by ESTRO or IAEA. 
Training of medical specialists in radia-
tion oncology and of medical physicists in the 
fi eld of radiation oncology is conducted in ac-
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Fig. 4. Number of Cancer patients and non-cancer patients treated with RT (2004) 
Fig. 5. Average number of treatment fi elds per 1 linear accelerator (LA) in Czech RT facilities (2004)
credited teaching centres. The six-year study 
programme meets the requirements of the 
Recommended Curriculum for the Specialist 
Training of Medical Practitioners in Radio-
therapy (Radiation Oncology) within Europe 
and allows radiation oncologists to prescribe 
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also chemotherapy, hormonal therapy and 
biological therapy. Accreditation is granted 
by the accreditation committee of the Czech 
Ministry of Health. 
Future perspectives of radiation oncology 
in the Czech Republic include:
– improvement of reimbursement of radio-
therapy;
– concentration of modern technology and 
specialists in large university centres;
– implementation of standards in radiation 
oncology and of clinical audits; 
Cancer location No. of patients (%)
Endometrium 832 (45.0 %)
Cervix 407 (22.0 %)
Breast 285 (15.5 %)
Skin 137 (7.5 %)
Bronchus 88 (4.8 %)
Prostate 23 (1.2 %)
Vagina 15 (0.8 %)
Other 14 (0.7 %)
Anus 13 (0.7 %)
Head and neck 12 (0.6 %)
Soft tissue sarcomas 8 (0.4 %)
Oesophagus 7 (0.4 %)
Vulva 6 (0.3 %)
Total 1847 (100 %)
Table 6. The number of newly diagnosed patients treated 
with brachytherapy (data from ESTRO survey, 2007)
Indicator Value
No. of radiotherapy (RT) facilities 28
No. of new patients treated with RT 26 764
No. of qualifi ed radiation oncologists 148
No. of radiation oncologists under training 65
No. of RT facilities with brachytherapy 16
No. of patients treated with brachytherapy 1847
No. of performed brachytherapy applications 7272
Table 5. Summary indicators of Czech radiotherapy (data from survey performed in 2007)
– improvement of multicentre and interna-
tional cooperation;
– support of research and publication 
activitiesł
– cooperation with other European countries 
[3].   
The Czech Society of Radiation Oncology, 
Biology and Physics in cooperation with the 
National Cancer Registry and Institute of Bio-
statistics and Analyses, Masaryk University, 
Brno, is now performing a study focused on 
the impact of access to radiotherapy on the 
results of oncological treatment in the Czech 
Republic.
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